|1.||Khanna, S K: 2 articles (09/2013 - 06/2001)|
|2.||Kalnina, Inta: 2 articles (12/2009 - 11/2007)|
|3.||Klimkane, Laura: 2 articles (12/2009 - 11/2007)|
|4.||Kirilova, Elena: 2 articles (12/2009 - 11/2007)|
|5.||Bruze, Magnus: 1 article (07/2014)|
|6.||Svedman, Cecilia: 1 article (07/2014)|
|7.||Zimerson, Erik: 1 article (07/2014)|
|8.||Kumar, Sandeep: 1 article (09/2013)|
|9.||Dwivedi, Neelam: 1 article (09/2013)|
|10.||Das, Mukul: 1 article (09/2013)|
|1.||Photosensitivity Disorders (Photodermatitis)
08/01/1985 - "The action spectrum for benzanthrone photosensitization of mouse macrophages."
09/01/1990 - "In skin-photosensitization studies on guinea-pigs benzanthrone induced significant erythema and oedema, depending upon the doses both of benzanthrone and of sunlight or artificially simulated UVA radiation. "
09/01/2013 - "Thus, attempts were made to elucidate the tumor initiating and promoting potentials of pure (PBA) and commercial benzanthrone (CBA). "
11/01/2007 - "The fluorescent probe-aminoderivative of benzanthrone, ABM (developed at Riga Technical University, Riga, Latvia) was used to characterize the membranes of lymphocytes of cancer patients: 46 patients with gastrointestinal diseases, 13 patients having different primary localizations with massive metastases and intoxication. "
12/01/2009 - "The fluorescent probe ABM (an amino derivative of benzanthrone) developed at Riga Technical University (Riga, Latvia) was used to characterize the blood plasma albumin of cancer patients (46 gastrointestinal cancer patients--30 with colorectal cancer in Stages II-IV and 16 with gastric cancer in Stage III) and of healthy controls. "
|4.||Body Weight (Weight, Body)
01/01/1991 - "Parenteral administration of benzanthrone (40 mg/kg body weight) for 3, 7, or 21 days caused no change in the relative body weight or organ weight of rats. "
06/01/2001 - "Oral administration of benzanthrone (50, 125 or 250 mg/kg body weight) resulted in a significant increase of urinary AsA levels with a concomitant decrease in the urinary dehydroascorbic acid (DHA) content in both rats and guinea-pigs. "
|5.||Phototoxic Dermatitis (Phototoxicity)
|2.||Coloring Agents (Dyes)